enGene Holdings Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +63.3% | -2.5% | +5.1% | +1.2% | +22.9% | +3.9% | +22.6% | +31.5% | +10.5% | -4.8% | -1.1% | – | |
| – | -91.3% | +558.8% | -23.8% | +13.4% | +9.2% | +46.5% | -2.6% | +1.0% | +7.6% | +47.9% | +88.4% | – | |
| – | -10.6% | -158.1% | – | -217.3% | – | – | -7.2% | +849.9% | -125.1% | – | – | – | |
| – | +266.7% | -64.6% | -98.9% | +11,800.0% | +25.6% | -84.9% | +1,464.4% | -37.9% | -65.0% | -35.9% | -100.0% | – | |
| – | +266.7% | -64.6% | -98.9% | +6,263,200.0% | -32.2% | – | -92.3% | +2,836.9% | -411.8% | – | +27.4% | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | -100.0% | – | – | |
| – | -76.4% | +1,512.5% | -100.0% | +117,860.8% | -100.0% | +19,800.0% | -435.2% | – | +7,015.0% | -99.9% | -68.9% | – | |
| – | -90.6% | +4,243.4% | -104.0% | – | – | – | – | – | -177.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.